Heparin inhibits the effect on factor Xa and thrombin and has beneficial effects in cancer thrombosis, including increased release of tissue factor pathway inhibitor from the vascular endothelium at sites of thrombosis, binding and neutralizing cytokines and chemokines, hence preventing microthrombi formation [38, 39]. This evidence concerns the gene F10 and cancer.